Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,289,903 papers from all fields of science
Search
Sign In
Create Free Account
CUL5 gene
Known as:
VASOPRESSIN-ACTIVATED CALCIUM-MOBILIZING RECEPTOR 1
, Cullin 5 Gene
, CUL5
Expand
This gene plays a role in cell cycle arrest, DNA repair and protein degradation.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Narrower (1)
CUL5 wt Allele
Cullin 5 Protein
Protein Degradation, Regulatory
Ubiquitination
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
MicroRNA-19a regulates the proliferation, migration and invasion of human gastric cancer cells by targeting CUL5.
Yu Zhu
,
Linhai Li
,
+5 authors
Kunmei Gong
Archives of Biochemistry and Biophysics
2019
Corpus ID: 54551902
2019
2019
MicroRNA-27a regulates the proliferation, chemosensitivity and invasion of human ovarian cancer cell lines by targeting Cullin 5.
Lihui Si
,
Yan Jia
,
Ruixin Lin
,
Wenwen Jian
,
Qing Yu
,
Shuli Yang
Archives of Biochemistry and Biophysics
2019
Corpus ID: 143432510
2018
2018
Structural basis for Cullins and RING component inhibition: Targeting E3 ubiquitin pathway conductors for cancer therapeutics.
Shagufta Shafique
,
Waqar Ali
,
Sonia Kanwal
,
Sajid Rashid
International Journal of Biological…
2018
Corpus ID: 41098232
2014
2014
Cellular Requirements for Bovine Immunodeficiency Virus Vif-Mediated Inactivation of Bovine APOBEC3 Proteins
Wenyan Zhang
,
Hong Wang
,
+4 authors
Xiao-Fang Yu
Journal of Virology
2014
Corpus ID: 31065884
ABSTRACT Human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) viral infectivity factor (Vif) form…
Expand
2014
2014
Evolutionarily Conserved Requirement for Core Binding Factor Beta in the Assembly of the Human Immunodeficiency Virus/Simian Immunodeficiency Virus Vif-Cullin 5-RING E3 Ubiquitin Ligase
Xue Han
,
Weizi Liang
,
+9 authors
Xiao-Fang Yu
Journal of Virology
2014
Corpus ID: 206817566
ABSTRACT The human immunodeficiency virus type 1 (HIV-1)-encoded virion infectivity factor (Vif) is required to inactivate the…
Expand
2013
2013
Dispersed and Conserved Hydrophobic Residues of HIV-1 Vif Are Essential for CBFβ Recruitment and A3G Suppression
Xiaohong Zhou
,
Xue Han
,
+8 authors
Xiao-Fang Yu
Journal of Virology
2013
Corpus ID: 206817246
ABSTRACT CBFβ was recently found to be a key regulator of the ability of human immunodeficiency virus type 1 (HIV-1) Vif to…
Expand
2011
2011
Effect of HIV-1 Vif variability on progression to pediatric AIDS and its association with APOBEC3G and CUL5 polymorphisms.
Federico De Maio
,
C. Rocco
,
P. Aulicino
,
R. Bologna
,
A. Mangano
,
L. Sen
Infection, Genetics and Evolution
2011
Corpus ID: 9231772
2010
2010
Identification of a Critical T(Q/D/E)x5ADx2(I/L) Motif from Primate Lentivirus Vif Proteins That Regulate APOBEC3G and APOBEC3F Neutralizing Activity
Y. Dang
,
Xiaojun Wang
,
I. York
,
Yong-Hui Zheng
Journal of Virology
2010
Corpus ID: 206799359
ABSTRACT Primate lentiviruses are unique in that they produce several accessory proteins to help in the establishment of…
Expand
2009
2009
Molecular structure and biochemical properties of the HCCH-Zn2+ site in HIV-1 Vif.
K. Giri
,
R. A. Scott
,
E. Maynard
Biochemistry
2009
Corpus ID: 27201665
Virion infectivity factor (Vif) is an HIV accessory protein that is essential for the infection of CD4(+) T cells. Vif recruits a…
Expand
2000
2000
Expression of the Genes Encoding the Vasopressin‐Activated Calcium‐Mobilizing Receptor and the Dual Angiotensin II/Vasopressin Receptor in the Rat Central Nervous System
Hurbin
,
Orcel
,
Ferraz
,
Moos
,
Rabié
Journal of neuroendocrinology
2000
Corpus ID: 29093075
The distributions of two newly discovered receptors, the vasopressin‐activated calcium‐mobilizing receptor (VACM‐1) and the dual…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE